Literature DB >> 15801575

The effect of a novel smoking system--Accord--on ongoing smoking and toxin exposure.

John R Hughes1, Josue P Keely.   

Abstract

Multiple potentially reduced exposure products (PREPs) are being introduced to the market, yet little is known about how they will be used and what their public health impact might be. To determine the impact of one such PREP--Accord--on ongoing smoking and toxin exposure, 11 smokers of light cigarettes were required to use increasing amounts of Accord (5, 10, and 15 per day) with the option of using their traditional cigarettes. Accord suppressed ongoing cigarettes per day and carbon monoxide (CO), but not cotinine, in a dose-dependent manner. Smoking 15 Accord per day decreased the number of traditional cigarettes smoked by 32% (-8.6 cigarettes per day) and CO levels by 27% (-5.9 ppm). However, Accord did not function as a perfect (i.e., one to one) substitute for cigarettes because the total number of nicotine products (Accord plus usual brand) per day increased by 24%. Participants believed that Accord was safer than traditional cigarettes but rated Accord as ineffective at suppressing cravings for cigarettes. These findings suggest that use of Accord results in significant decreases in cigarettes smoked and CO exposure. Whether these reductions will translate into health benefits or endure beyond 2 weeks is unknown. Because most PREPs will probably be used along with traditional cigarettes, their net health impact is a function of not only their toxicological profile but also their effect on ongoing smoking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15801575     DOI: 10.1080/14622200412331296011

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  11 in total

1.  A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.

Authors:  Andrea R Vansickel; Caroline O Cobb; Michael F Weaver; Thomas E Eissenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.

Authors:  Jennifer N Gray; Alison B Breland; Michael Weaver; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2008-09       Impact factor: 4.244

Review 3.  Measures for assessing subjective effects of potential reduced-exposure products.

Authors:  Karen Hanson; Richard O'Connor; Dorothy Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

4.  Answering questions about electronic cigarettes using a multidisciplinary model.

Authors:  Alison Breland; Robert L Balster; Caroline Cobb; Pebbles Fagan; Jonathan Foulds; J Randy Koch; Thokozeni Lipato; Najat Saliba; Alan Shihadeh; Shumei Sun; Thomas Eissenberg
Journal:  Am Psychol       Date:  2019-04

5.  Expanding clinical laboratory tobacco product evaluation methods to loose-leaf tobacco vaporizers.

Authors:  Alexa A Lopez; Marzena Hiler; Sarah Maloney; Thomas Eissenberg; Alison B Breland
Journal:  Drug Alcohol Depend       Date:  2016-10-11       Impact factor: 4.492

6.  Evaluating oral noncombustible potential-reduced exposure products for smokers.

Authors:  Melissa D Blank; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2010-02-16       Impact factor: 4.244

Review 7.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

8.  Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers.

Authors:  C O Cobb; M F Weaver; T Eissenberg
Journal:  Tob Control       Date:  2009-04-02       Impact factor: 7.552

9.  Acute effects of JUUL and IQOS in cigarette smokers.

Authors:  Sarah Maloney; Alisha Eversole; Melanie Crabtree; Eric Soule; Thomas Eissenberg; Alison Breland
Journal:  Tob Control       Date:  2020-02-10       Impact factor: 7.552

10.  Reduced Exposure to Harmful and Potentially Harmful Smoke Constituents With the Tobacco Heating System 2.1.

Authors:  Frank Lüdicke; Gizelle Baker; John Magnette; Patrick Picavet; Rolf Weitkunat
Journal:  Nicotine Tob Res       Date:  2016-07-01       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.